Michael Kornacker
23Patents
6h-index
19Co-inventors
66Inventor score
Filing activity: Dec 10, 1997 → Feb 2, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11078282B2 | CD80 variant immunomodulatory proteins and uses thereof | Chemistry; Metallurgy | 14 | Active |
| US11117950B2 | CD80 variant immunomodulatory proteins and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US11117948B2 | CD80 variant immunomodulatory proteins and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US11117949B2 | CD80 variant immunomodulatory proteins and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US11096988B2 | CD80 variant immunomodulatory proteins and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US10882914B2 | ICOS ligand variant immunomodulatory proteins and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US7314726B2 | Beta secretase exosite binding peptides and methods for identifying beta secretase modulators | Chemistry; Metallurgy | 6 | Expired |
| US11319359B2 | Immunomodulatory proteins with tunable affinities | Emerging Cross-Sectional Technologies | 6 | Active |
| US6051381A | Prokaryotic two-hybrid system | Chemistry; Metallurgy | 5 | Expired |
| US9605024B2 | PAR4 agonist peptides | Human Necessities | 4 | Active |
| US11230588B2 | CD80 variant immunomodulatory proteins and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US7713699B2 | Methods of diagnosing colon adenocarcinoma using mRNA encoding the human g-protein coupled receptor, HGPRBMY23 | Emerging Cross-Sectional Technologies | 1 | Active |
| US11613566B2 | Variant ICOS ligand immunomodulatory proteins and related compositions and methods | Chemistry; Metallurgy | 1 | Active |
| US11639375B2 | CD80 variant immunomodulatory proteins and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US9303065B2 | PAR4 agonist peptides | Human Necessities | 1 | Active |
| US8927688B2 | PAR4 agonist peptides | Human Necessities | 1 | Active |
| US12110339B2 | ICOS ligand variant immunomodulatory proteins and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11471488B2 | CD155 variant immunomodulatory proteins and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11834490B2 | CD112 variant immunomodulatory proteins and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11732022B2 | PD-L2 variant immunomodulatory proteins and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11498967B2 | CD80 variant immunomodulatory proteins and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11479609B2 | CD80 variant immunomodulatory proteins and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11359022B2 | CD80 variant immunomodulatory proteins and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.